News

As per the alliance, the high-level cancer research technology and clinical experience of the National Cancer Center will be integrated with the advanced research and drug discovery capabilities

The new Period Vitamin will provide vitamins and minerals that are required for women’s health, as well as offer herbs to target specific premenstrual syndrome (PMS) symptoms. Period

In return, Marina will receive royalties from the sale of CRN-based oligonucleotide reagents as well as a robust supply of cGMP material for Marina and its partners’ pre-clinical,

The state government is formulating a new drug policy that will allow the state health department to procure these drugs for government hospitals, unlike earlier the department used

Actimmune, a synthesized version of interferon gamma – a naturally occurring protein believed to stimulate the immune system, is indicated for the treatment of two life-threatening congenital diseases:

Aushon’s microarray printing, novel assay design, astronomy-grade imaging and advanced analytics provide the sensitivity and reproducibility of single-plexed ELISA in a multiplexed format. The technology is expected to

As part of the partnership, CHDI will conduct pre-clinical studies on a Lundbeck investigative compound to determine the compound’s effect on P2X receptors that may be involved in

The companies plan to invest $50m in the expansion project following the World Health Organization (WHO) approval, reports AllAfrica. The plant, which currently manufactures six million tablets per

The recruitment of half of target patient population triggered a €10m milestone payment from Ipsen to Active Biotech. Ipsen chairman and chief executive officer Marc de Garidel said